Studies on the Synthesis of 1-Hydroxycarbapenems

1-히드록시카르바페넴의 합성에 관한 연구

  • You, Jong Hyeon (Department of Chemistry, Seoul National University) ;
  • Park, Jeong Ho (Department of Chemistry, Seoul National University) ;
  • Goo, Yang Mo (Department of Pharmacy, Seoul National University) ;
  • Lee, Yun Yeong (Department of Chemistry, Seoul National University)
  • 유종현 (서울대학교 자연과학대학 화학과) ;
  • 박정호 (서울대학교 자연과학대학 화학과) ;
  • 구양모 (서울대학교 약학대학 약학과) ;
  • 이윤영 (서울대학교 자연과학대학 화학과)
  • Published : 19980200

Abstract

(3S,4S)-1-(t-Butoxycarbonylmethyl)-3-[(S)-1-(t-butyldimethylsilyloxy)ethyl]-4-(2-diazo-2-ethoxycarbonyl-1-oxoethyl)-2-azetidinone (14) was prepared from 4-styryl-2-azetidinone 7b via a sequence of reactions involving N-alkylation with bromoacetate, ozonolysis, oxidation, condensation with magnesium ethyl malonate, and diazo transfer reaction. (3S,4S)-3-[(S)-1-(t-Butyldimethylsilyloxy)ethyl]-4-(3-diazo-3-ethoxycarbonyl1-hydroxypropyl)-2-azetidinone (21) was also prepared from 4-formyl-2-azetidinone 5b via a sequence of reactions involving Wittig reaction, 1,3-dipolar cycloaddition with ethoxycarbonylformonitrile oxide, catalytic hydrogenation, and diazotization. However, the final cyclization of 14 or 21 to 1-hydroxycarbapenem or 1-hydroxycarbapenam by treating with $Rh_2(OAc)_4$ was unsuccessful.

4-styryl-2-azetidinone 7b의 bromoacetate에 의한 N-알킬화, 가오존분해, 산화, 말론산 에틸 마그네슘과의 축합 및 디아조 전달반응의 일련의 과정을 거처서 (3S,4S)-1-(t-butoxycarbonylmethyl)-3-[(S)-1-(t-butyldimethylsilyloxy)ethyl]-4-(2-diazo-2-ethoxycarbonyl-1-oxoethyl)-2-azetidinone(14)을 합성하였다. 또한 4-formyl-2-azetidinone 5b 의 Wittig 반응, ethoxycarbonylformonitrile oxide와의 1,3 이중극성 고리화 첨가반응, 촉매 수소화 및 디아조화 반응의 일련의 과정을 거쳐서 (3S,4S)-3-[(S)-1-(t-butyldimethylsilyloxy)ethyl]-4-(3-diazo-3-ethoxycarbonyl-1-hydroxypropyl)-2-azetidinone(21)을 합성하였다. 그러나 화합물 14 또는 21을 $Rh_2(OAc)_4$ 로 처리하여 1-hydroxycarbapenem 또는 1-hydroxycarbapenam으로 고리화하는 것을 성공하지 못하였다.

Keywords

References

  1. J. Antibiotics v.32 Kahan, J. S.;Kahan, F. M.;Goegelman, R.;Currie, S. A.;Jackson, M.;Stapley, E. O.;Miller, T. W.;Miller, A. K.;Hendlin, D.;Mochales, S.;Hernandez, S.;Woodruff, H. B.;Birnbaum, J.
  2. J. Am. Chem. Soc. v.100 Albers-Schonberg, G.;Arison, B. H.;Hensens, O. D.;Hirshfield, J.;Hoogsteen, K.;Kaczka, E. A.;Rhones, R. E.;Kahan, J. S.;Kahan, F. M.;Ratcliffe, R. W.;Walton, E.;Ruswinkle, L. J.;Morin, R. B.;Christensen, B. G.
  3. Antimicrob. Agents Chemother v.22 Kropp, H.;Sundelot, J. G.;Hajdu, R.;Kahan, F. M.
  4. J. Med. Chem v.22 Leanza, W. J.;Wildonger, K. J.;Miller, T. W.;Christensen, B. G.
  5. Heterocycles v.21 Shih, D. H.;Baker, F.;Cama, L.;Christensen, B. G.
  6. US Appl. 603,005;Chem. Abstr. v.105 Cama, L. D.;Christensen, B. G.;Shih, D. H.
  7. Eur. Pat. Appl. EP 160,876;Chem. Abstr. v.105 Cama, L. D.;Christensen, B. G.;Shih, D. H.
  8. J. Am. Chem. Soc. v.106 Ha, D. C.;Hart, D. J.;Yang, T. K.
  9. J. Antibiotics v.40 Ha, D. C.;Hart, D. J.
  10. Chem. Lett. Chiba, T.;Nagatsuma, M.;Nakai, T.
  11. Tetrahedron Lett. Hart, D. J.;Ha, D. C.
  12. Tetrahedron Lett. Cainelli, G.;Contento, M.;Giacomini, D.;Panunzio, M.
  13. Tetrahedron v.45 Hart, D. J.;Ha, D. C.
  14. Tetrahedron Lett. Georg, G. I.
  15. Tetrahedron Lett. Georg, G. I.;Gill, H. S.;Gerhardt, C.
  16. J. Am. Chem. Soc. v.109 Georg, G. I.;Kant, J.;Gills, H. S.
  17. J. Chem. Soc., Perkin Trans. I Cainelli, G.;Panunzio, M.;Bongini, A.;Giacomini, D.;Martelli, G.
  18. Tetrahedron Lett. Ha, D. C.;Hart, D. J.
  19. Angew. Chem. Int. Ed. Engl. v.1 Masamune, S.;Brooks, D. W.
  20. J. Org. Chem. v.48 Kozikowski, A. P.;Adamcjyk, N.